Our-mission_LightCover Image

Our Mission

Through DNA methylation blood testing, we provide more accurate and convenient cancer detection technology and data analysis, helping patients live healthier and longer lives.

Empowering Cancer Patients for a Healthier Future

We are EG BioMed, a biotechnology company dedicated to cancer detection and treatment.

We believe data is the key to medical decision-making. Through advanced blood testing technology and precise data analysis, we provide doctors with reliable insights to develop more effective treatment plans. Our goal is to make early cancer detection the norm, improve patients’ quality of life, and reduce the challenges that come with cancer.

cfDNA-PCR-only

Versatile Applications of Cancer Detection

With continuous advancements in medical technology, early cancer detection and treatment management have entered a new era. Through cutting-edge precision testing, we can not only identify early signs of cancer in routine blood tests but also provide more effective screening solutions for hard-to-diagnose cancers.

For post-surgical patients, these technologies help doctors assess the risk of recurrence and offer long-term monitoring support, ultimately reducing the chances of relapse. In late-stage cancer treatment, they enable doctors to tailor the most suitable treatment plans and make real-time adjustments based on the patient’s condition.

多元檢測
Cancer screening made easy_purple Icon

Cancer Screening Made Easy

Through a single blood test, routine blood draws can become an early warning tool for cancer screening.

Early detection brings peace of mind_purple Icon

Early Detection for Greater Peace of Mind

For hard-to-diagnose cancers, precise testing helps patients start treatment earlier.

Postoperative management is guaranteed_purple Icon

Postoperative Management Guaranteed

Helps doctors manage the risk of recurrence after surgery and provides long-term follow-up to reduce the chance of relapse.

There is a direction for late-stage treatment_purple Icon

Guidance for Late-Stage Treatment

Helps doctors create the most suitable treatment plan for late-stage cancer patients, assisting in the selection of the most effective treatment method and adjusting strategies as the condition evolves.

Accelerating new drug development_purple Icon

Accelerating New Drug Development

Provides high-precision genetic data and clinical research support to accelerate the development of next-generation precision medicine, allowing more patients to benefit sooner.

Joining Hands Against Cancer, Safeguarding Health

Cancer is one of the leading causes of death worldwide, often striking like a sudden storm, profoundly affecting us and our loved ones. This challenge not only burdens patients physically and mentally but also leaves families feeling helpless and anxious.

Understanding this sense of helplessness, we are dedicated to developing precise and convenient diagnostic technologies to improve early disease detection. This enables patients to receive timely treatment, improving their prognosis and allowing them to better manage their health, leading to a healthier and more secure life.